Latest lung disease News

Pollution Data highlights the need to shut Eraring
Discovery into how chronic lung conditions affect children’s immune system
WHO unveils a digital health promoter harnessing generative AI for public health
RACGP applauds NSW RSV immunisation rollout
Hot tubs are as full of nasty germs as you fear
Curtin’s ‘Emerging Leaders’ win millions for health research
MRFF Grants To Boost Children’s Health And Wellbeing
Engineered Stone Ban In Effect From 1 July 2024
Omega-3 fatty acids are linked to better lung health, particularly in patients with pulmonary fibrosis
Targeting inflammatory protein could help treat severe asthma
Acquisition Of Gracell Completed
Important health and safety update
Heat up your breath during cold weather
Research reveals gut’s crucial role in lung disease
WorkCover Queensland CEO Bruce Watson retiring
Victorians Urged To Take Care As Temperatures Soar
Call to stay vigilant for symptoms of melioidosis as heavy rains continue
Mosquito and mould advice post flood
The Government must ban engineered stone to protect workers’ health
Changes to workplace exposure standard for welding fumes
UQ develops tool to identify dust lung disease risk
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
Results from the Tasmanian Population Health Survey 2022 released
Animal-Free Science Advocacy Celebrates Funder Decision on Forced Smoking Research
Engineered stone prohibition to make workplaces safer and healthier for all Australians
Queensland’s engineered stone campaign culminates in national ban
D-Day for engineered stone ban
Silica is not only hazard in engineered stone
Health professionals join coal port blockade
Premature baby Charlotte is mango-sized miracle
Smoking is the leading cause of chronic obstructive pulmonary disease
Major retailers join Queensland’s engineered stone campaign
Pivotal role of TLR7 protein revealed in lung disease
Are you silica smart?
AWU welcomes Safe Work recommendation to ban engineered stone
Cumberland Council encourages residents to stay informed about the dangers of asbestos this November for National Asbestos Awareness Month
About 100 people a month are diagnosed with lung cancer in WA
Australia’s tenth annual National Asbestos Awareness Month launches new Asbestos Education resource for residential property owners, managers and tradies to help save lives
Multi-million dollar boost into child research programs
PHAA backs ban on engineered stone products
Datopotamab deruxtecan improved progression-free survival vs. chemotherapy in patients with previously treated non-small cell lung cancer in TROPION-Lung01 Phase III trial
Datopotamab deruxtecan significantly extended progression-free survival vs. chemotherapy in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial
Datopotamab deruxtecan plus Imfinzi demonstrated robust and durable tumour responses in 1st-line treatment of patients with metastatic triple-negative breast cancer in BEGONIA…
Breakthrough in understanding immune responses in inflammatory bowel and lung disease
COVID-19 first infectious disease in top 5 causes of death since 1970
Accelerated silicosis update
Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01…
Delivering hope: anti-inflammatory drug trial for preterm babies